Literature DB >> 7299334

The prevalence of multiple sclerosis in the Outer Hebrides compared with north-east Scotland and the Orkney and Shetland Islands.

G Dean, J Goodall, A Downie.   

Abstract

Multiple sclerosis has been reported to have a high prevalence in the Orkney and Shetland Islands and in Caithness in comparison with the highlands of Scotland and the Outer Hebrides-the Western Isles. For this reason a survey was undertaken in the Outer Hebrides and 25 probable and 30 probable and possible patients with multiple sclerosis were found. This is an increase from eight and 11 respectively found in 1954. The present prevalence rate of 97.3 per 100 000 for probable and possible multiple sclerosis is not significantly different from that found in a recent study in the Grampian region in north-east Scotland. Repeated studies in small populations generally show increasing prevalence of multiple sclerosis because some patients are missed in the earlier studies, and over a long period of time there may also be some increase in survival time. This increase has been found in the Orkney and Shetland Islands, in north-east Scotland, and also in the Outer Hebrides.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7299334      PMCID: PMC1052134          DOI: 10.1136/jech.35.2.110

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  4 in total

1.  Observations on the prevalence of multiple sclerosis in Northern Scotland.

Authors:  J M SUTHERLAND
Journal:  Brain       Date:  1956-12       Impact factor: 13.501

2.  A further prevalence study of multiple sclerosis in north-east Scotland.

Authors:  D I Shepherd; A W Downie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-04       Impact factor: 10.154

3.  Prevalence of multiple sclerosis in north-east Scotland.

Authors:  D I Shepherd; A W Downie
Journal:  Br Med J       Date:  1978-07-29

4.  HLA antigens and IgG allotypes on the Island of Barra (Outer Hebrides).

Authors:  H M Dick; M M Izatt
Journal:  Ann Hum Biol       Date:  1978-09       Impact factor: 1.533

  4 in total
  11 in total

1.  The prevalence of multiple sclerosis in the Leeds Health Authority.

Authors:  H L Ford; E Gerry; C M Airey; A Vail; M H Johnson; D R Williams
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-05       Impact factor: 10.154

2.  The distribution of multiple sclerosis in the United Kingdom.

Authors:  R J Swingler; D Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-10       Impact factor: 10.154

3.  Epidemiology of multiple sclerosis in the north-east (Grampian region) of Scotland--an update.

Authors:  J G Phadke; A W Downie
Journal:  J Epidemiol Community Health       Date:  1987-03       Impact factor: 3.710

4.  Surveying multiple sclerosis in the United Kingdom.

Authors:  N Robertson; A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

5.  The prevalence of multiple sclerosis in Sicily. II: Agrigento city.

Authors:  G Dean; G Savettieri; D Giordano; C Butera; G Taibi; S Morreale; L Karhausen
Journal:  J Epidemiol Community Health       Date:  1981-06       Impact factor: 3.710

6.  The characteristics of a national register of people with multiple sclerosis (MS): a comparison between the ARMS (Action for Research into Multiple Sclerosis) register and 10 British MS populations.

Authors:  J Monks; I Robinson
Journal:  J Epidemiol Community Health       Date:  1989-06       Impact factor: 3.710

7.  Genome-wide homozygosity and multiple sclerosis in Orkney and Shetland Islanders.

Authors:  Rebekah E McWhirter; Ruth McQuillan; Elizabeth Visser; Carl Counsell; James F Wilson
Journal:  Eur J Hum Genet       Date:  2011-09-07       Impact factor: 4.246

8.  The epidemiology of multiple sclerosis in Scotland: inferences from hospital admissions.

Authors:  Adam E Handel; Lynne Jarvis; Ryan McLaughlin; Anastasia Fries; George C Ebers; Sreeram V Ramagopalan
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

Review 9.  Epidemiologic evidence for multiple sclerosis as an infection.

Authors:  J F Kurtzke
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

10.  Multiple sclerosis in Malta in 1999: an update.

Authors:  G Dean; M Elian; A Galea de Bono; R Pace Asciak; N Vella; V Mifsud; J Aquilina
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.